May 12, 2023 6:01 pm Published by admin During the past three years many CS Patients, caregivers, family members and friends have supported the Foundation through their donations and fund-raising activities. We received donations from family members in honor of their lost loved ones to this beast. We have had others like Julie Mathews that supported 5K walk / runs. Lifecycle holdings in [...]
May 11, 2023 12:27 am Published by admin BOWIE, Maryland, May 12—The Chondrosarcoma (CS) Foundation will commemorate its third anniversary by continuing to educate the public about this rare bone cancer, advocate for patients fighting the disease and conduct a global natural history study. On May 14, 2020, the CS Foundation was incorporated, six months after Shayna Elise Kramer lost her battle with [...]
April 28, 2023 6:30 pm Published by admin The Chondrosarcoma Foundation in partnership with NORD® launched the Chondrosarcoma Patient Registry on March 1, 2023. The Chondrosarcoma Patient Registry is a platform for patients around the world to strengthen their voices and collectively share information about this rare bone cancer. This global resource will provide data for researchers to use to advance drug development [...]
April 22, 2023 2:25 am Published by admin Journal of Clinical Pathology J Clin Pathol. 2018 Jul; 71(7): 579–583. Published online 2018 Mar 28. doi: 10.1136/jclinpath-2018-205071 PMCID: PMC6204964 PMID: 29593061 Biomarkers of chondrosarcoma Wonju Jeong1 and Ha-Jeong Kim2,3 Abstract Clinical outcome prediction is major concern to patients with cancer. Various molecular markers in various carcinomas have been identified in the past few decades. [...]
April 11, 2023 9:01 pm Published by admin The INBRX 109 Clinical Trials will shortly resume recruiting patients for their Phase 2 Clinical Trial treating patients with Conventional Chondrosarcoma with recurrence or metastasis. Listed below is a response from Inhibrx: We have just released our newest amendment to the protocol for both the Phase 2 and Phase I INBRX-109. These protocols both now [...]
April 7, 2023 8:10 pm Published by admin The Chondrosarcoma Foundation in partnership with NORD® launched the Chondrosarcoma Patient Registry on March 1, a little over one month ago. The registry currently has 60 participants. We want to encourage everyone in the community to participate. The patient information that the registry collects will help give direction to scientists on areas in which to [...]
March 29, 2023 1:12 am Published by admin Antoine Gilbert 1, Mihaela Tudor 2,3, Juliette Montanari 1, Kevin Commenchail 1 , Diana Iulia Savu 2 ,Paul Lesueur 4,5,6 and François Chevalier 1,* Simple Summary: This review article aims in describing the origins of chondrosarcoma radiation-resistance and proposes several potential solutions in order to improve the treatment, in regard with tumor grade and characteristics. [...]
March 23, 2023 12:44 am Published by admin Some of you may not know who Amber Sarcone is. In Philly, she’s a part of the royal family. Her family runs Sarcone’s Bakery, makers of some of the most delicious damn bread you’ll ever have the pleasure of shoving into your mouth. Her cousin is Danny, who owns Angelo’s Pizzeria–makers of the best cheesesteak [...]
March 16, 2023 8:36 pm Published by admin A research team led by Dr Darrell Green, a trustee of the Bone Cancer Research Trust, have identified a new drug that works against all main forms of bone cancer. Researchers at the University of East Anglia discovered that the drug, called ‘CADD522’, works by blocking a gene associated with metastatic disease. Preliminary studies suggest [...]
March 15, 2023 6:22 pm Published by admin The Chondrosarcoma Foundation in partnership with the National Organization for Rare Disorders (NORD®) has launched the Chondrosarcoma Patient Registry. The patient registry creates a platform for patients around the world to strengthen their voices and provide critical information about their experiences living with this rare bone cancer. This global resource will provide data for researchers [...]